1208 related articles for article (PubMed ID: 19853105)
1. Prospective, randomized clinical trial of the FloSeal matrix sealant in cardiac surgery.
Nasso G; Piancone F; Bonifazi R; Romano V; Visicchio G; De Filippo CM; Impiombato B; Fiore F; Bartolomucci F; Alessandrini F; Speziale G
Ann Thorac Surg; 2009 Nov; 88(5):1520-6. PubMed ID: 19853105
[TBL] [Abstract][Full Text] [Related]
2. Prospective, randomized, controlled clinical trial of a novel matrix hemostatic sealant in children undergoing adenoidectomy.
Mathiasen RA; Cruz RM
Otolaryngol Head Neck Surg; 2004 Nov; 131(5):601-5. PubMed ID: 15523433
[TBL] [Abstract][Full Text] [Related]
3. Reducing blood loss at myomectomy with use of a gelatin-thrombin matrix hemostatic sealant.
Raga F; Sanz-Cortes M; Bonilla F; Casañ EM; Bonilla-Musoles F
Fertil Steril; 2009 Jul; 92(1):356-60. PubMed ID: 19423098
[TBL] [Abstract][Full Text] [Related]
4. Prospective, randomized, controlled clinical trial of a novel matrix hemostatic sealant in patients with acute anterior epistaxis.
Mathiasen RA; Cruz RM
Laryngoscope; 2005 May; 115(5):899-902. PubMed ID: 15867662
[TBL] [Abstract][Full Text] [Related]
5. Hemostasis in endoscopic sinus surgery using a specific gelatin-thrombin based agent (FloSeal).
Baumann A; Caversaccio M
Rhinology; 2003 Dec; 41(4):244-9. PubMed ID: 14750353
[TBL] [Abstract][Full Text] [Related]
6. Comparison of a new fibrin sealant with standard topical hemostatic agents.
Schwartz M; Madariaga J; Hirose R; Shaver TR; Sher L; Chari R; Colonna JO; Heaton N; Mirza D; Adams R; Rees M; Lloyd D
Arch Surg; 2004 Nov; 139(11):1148-54. PubMed ID: 15545559
[TBL] [Abstract][Full Text] [Related]
7. Prospective, randomized, controlled trial of a hemostatic sealant in children undergoing adenotonsillectomy.
Jo SH; Mathiasen RA; Gurushanthaiah D
Otolaryngol Head Neck Surg; 2007 Sep; 137(3):454-8. PubMed ID: 17765775
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of the use of novel matrix hemostatic sealant (FloSeal) to achieve hemostasis during laparoscopic excision of endometrioma.
Angioli R; Muzii L; Montera R; Damiani P; Bellati F; Plotti F; Zullo MA; Oronzi I; Terranova C; Panici PB
J Minim Invasive Gynecol; 2009; 16(2):153-6. PubMed ID: 19138574
[TBL] [Abstract][Full Text] [Related]
9. Randomized clinical trial of fibrin sealant in patients undergoing resternotomy or reoperation after cardiac operations. A multicenter study.
Rousou J; Levitsky S; Gonzalez-Lavin L; Cosgrove D; Magilligan D; Weldon C; Hiebert C; Hess P; Joyce L; Bergsland J
J Thorac Cardiovasc Surg; 1989 Feb; 97(2):194-203. PubMed ID: 2464722
[TBL] [Abstract][Full Text] [Related]
10. Use of FloSeal hemostatic sealant in transsphenoidal pituitary surgery: technical note.
Ellegala DB; Maartens NF; Laws ER
Neurosurgery; 2002 Aug; 51(2):513-5; discussion 515-6. PubMed ID: 12182794
[TBL] [Abstract][Full Text] [Related]
11. Improved hemostasis during laparoscopic partial nephrectomy using gelatin matrix thrombin sealant.
Gill IS; Ramani AP; Spaliviero M; Xu M; Finelli A; Kaouk JH; Desai MM
Urology; 2005 Mar; 65(3):463-6. PubMed ID: 15780356
[TBL] [Abstract][Full Text] [Related]
12. Controlled clinical trial of a novel hemostatic agent in cardiac surgery. The Fusion Matrix Study Group.
Oz MC; Cosgrove DM; Badduke BR; Hill JD; Flannery MR; Palumbo R; Topic N
Ann Thorac Surg; 2000 May; 69(5):1376-82. PubMed ID: 10881808
[TBL] [Abstract][Full Text] [Related]
13. Comparative safety and efficacy of topical hemostatic agents in a rat neurosurgical model.
Ereth MH; Schaff M; Ericson EF; Wetjen NM; Nuttall GA; Oliver WC
Neurosurgery; 2008 Oct; 63(4 Suppl 2):369-72; discussion 372. PubMed ID: 18981845
[TBL] [Abstract][Full Text] [Related]
14. Use of floseal hemostatic matrix for control of hemostasis during laparoscopic cholecystectomy for acute cholecystitis: a multicenter historical control group comparison (the GLA study gelatin matrix for acute cholecystitis).
Sartelli M; Catena F; Biancafarina A; Tranà C; Piccardo A; Ceccarelli G; Tirone G; Agresta F; Di Giorgio A; Catani M; Tricarico F; Buonanno M; Piazza L
J Laparoendosc Adv Surg Tech A; 2014 Dec; 24(12):837-41. PubMed ID: 25025393
[TBL] [Abstract][Full Text] [Related]
15. A gelatin-thrombin matrix for hemostasis after endoscopic sinus surgery.
Woodworth BA; Chandra RK; LeBenger JD; Ilie B; Schlosser RJ
Am J Otolaryngol; 2009; 30(1):49-53. PubMed ID: 19027513
[TBL] [Abstract][Full Text] [Related]
16. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
[TBL] [Abstract][Full Text] [Related]
17. Hemostatic matrix sealant in neurosurgery: a clinical and imaging study.
Gazzeri R; Galarza M; Neroni M; Alfieri A; Giordano M
Acta Neurochir (Wien); 2011 Jan; 153(1):148-54; discussion 155. PubMed ID: 20703888
[TBL] [Abstract][Full Text] [Related]
18. Use of a novel topical hemostatic sealant in lacrimal surgery: a prospective, comparative study.
Durrani OM; Fernando AI; Reuser TQ
Ophthalmic Plast Reconstr Surg; 2007; 23(1):25-7. PubMed ID: 17237685
[TBL] [Abstract][Full Text] [Related]
19. Control of major pulmonary artery bleeding with a gelatin matrix-thrombin solution: a retrospective analysis.
Cardillo G; Carleo F; DI Martino M; Ciamberlano B; Ialongo P; Cusumano G; Denitza Tinti M; Ricci A; Cafarotti S
J Cardiovasc Surg (Torino); 2017 Dec; 58(6):904-908. PubMed ID: 26337014
[TBL] [Abstract][Full Text] [Related]
20. Gelatin matrix treatment of complex renal injuries in a porcine model.
Hick EJ; Morey AF; Harris RA; Morris MS
J Urol; 2005 May; 173(5):1801-4. PubMed ID: 15821591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
